-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Empower Clinics Announces Closing of Private Placement, Resignation of Auditor and Resignation of MediSure Canada Inc. President
Empower Clinics Announces Closing of Private Placement, Resignation of Auditor and Resignation of MediSure Canada Inc. President
VANCOUVER BC / ACCESSWIRE / December 14, 2022 / EMPOWER CLINICS INC. (CSE:EPW)(OTCQB:EPWCF) ("Empower" or the "Company") today announces that on December 13, 2022, it completed a non-brokered private placement of units (each a "Unit") at a price of $0.05 per Unit, for aggregate gross proceeds of $842,500 (the "Financing"). In connection with the Financing, the Company issued 16,850,000 Units, comprised of (i) 14,850,000 Units issued as settlement of $742,500 in outstanding debt and (ii) 2,000,000 Units issued for cash proceeds of $100,000.
Each Unit consists of one common share in the capital of the Company (each, a "Share") and one Share purchase warrant (each, a "Warrant"). Each Warrant is exercisable into one Share at $0.075 per share until two years from closing.
The Units are subject to a four-months and one-day hold period under applicable securities laws.
The proceeds of the Financing are expected to be used for working capital purposes and general administrative expenses.
The Company also announces that, effective December 13, 2022, MNP, LLP has resigned as auditor of the Company and a replacement auditor will be named in the near future.
The Company also announces a leadership transition at MediSure Canada Inc. Mario Cortis, President of MediSure Canada Inc., has resigned and the Company will soon announce an interim leader as part of this transition as well as recruitment for a permanent President. Empower would like to thank Mr. Cortis for his contributions and wish him well for his future endeavours.
ABOUT EMPOWER
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Its Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Media:
Steven McAuley CEO
s.mcauley@empowerclinics.com
+1 855-855-9058
Investors:
Tamara Mason
Business Development &
Communications
t.mason@empowerclinics.com
+1 855-855-9058
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding the expected use of proceeds of the Financing and the expected timing of an interim and permanent replacement President of MediSure Canada Inc. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that the Financing may not be completed on the terms expected or at all, and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
SOURCE: Empower Clinics Inc.
View source version on accesswire.com:
VANCOUVER BC / ACCESSWIRE / December 14, 2022 / EMPOWER CLINICS INC. (CSE:EPW)(OTCQB:EPWCF) ("Empower" or the "Company") today announces that on December 13, 2022, it completed a non-brokered private placement of units (each a "Unit") at a price of $0.05 per Unit, for aggregate gross proceeds of $842,500 (the "Financing"). In connection with the Financing, the Company issued 16,850,000 Units, comprised of (i) 14,850,000 Units issued as settlement of $742,500 in outstanding debt and (ii) 2,000,000 Units issued for cash proceeds of $100,000.
溫哥華BC/ACCESSWIRE/2022年12月14日/Empower Clinics Inc. (CSE:EPW)(場外市場:EPWCF) ("增強能力“或”公司“)今天宣佈,於2022年12月13日,完成了一項非仲介私募單位(每個單位單位“),每單位售價0.05元,總收益為842,500元(”融資與融資有關,本公司發行了16,850,000個單位,包括(I)14,850,000個單位以清償742,500美元的未償債務及(Ii)2,000,000個單位作為現金收益100,000美元而發行。
Each Unit consists of one common share in the capital of the Company (each, a "Share") and one Share purchase warrant (each, a "Warrant"). Each Warrant is exercisable into one Share at $0.075 per share until two years from closing.
每個單位由公司股本中的一股普通股組成(每股,一股分享)及一份股份認購權證(各一份搜查令“)。每份認股權證可按每股0.075美元行使為一股,直至交易結束起計兩年。
The Units are subject to a four-months and one-day hold period under applicable securities laws.
根據適用的證券法,該等單位須受四個月零一天的持有期限制。
The proceeds of the Financing are expected to be used for working capital purposes and general administrative expenses.
融資所得預計將用於營運資金用途和一般行政費用。
The Company also announces that, effective December 13, 2022, MNP, LLP has resigned as auditor of the Company and a replacement auditor will be named in the near future.
本公司還宣佈,自2022年12月13日起,MNP,LLP已辭去本公司核數師一職,並將在不久的將來任命一名替代核數師。
The Company also announces a leadership transition at MediSure Canada Inc. Mario Cortis, President of MediSure Canada Inc., has resigned and the Company will soon announce an interim leader as part of this transition as well as recruitment for a permanent President. Empower would like to thank Mr. Cortis for his contributions and wish him well for his future endeavours.
該公司還宣佈了MediSure加拿大公司的領導層換屆。MediSure加拿大公司的馬利奧·科蒂斯和總裁已經辭職,公司不久將宣佈一位臨時領導人,作為這一換屆的一部分,並招聘一名永久總裁。Enpower謹感謝科蒂斯先生的貢獻,並祝願他今後的工作一切順利。
ABOUT EMPOWER
關於授權
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Its Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
Empower是一家綜合性醫療保健公司,通過其診所、數位和遠端醫療護理、醫療設備公司和世界級醫療診斷實驗室為患者提供身心健康。在經驗豐富的領導團隊的支持下,Empower正在北美地區積極擴大其臨床和數字業務。其健康與健康和診斷與技術業務部門的定位是積極影響我們患者的綜合健康,同時為我們的股東提供長期價值。
ON BEHALF OF THE BOARD OF DIRECTORS:
我謹代表董事會:
Steven McAuley
Chief Executive Officer
史蒂文·麥考利
首席執行官
CONTACTS:
聯繫人:
Media:
媒體:
Steven McAuley CEO
s.mcauley@empowerclinics.com
+1 855-855-9058
史蒂文·麥考利首席執行官
郵箱:s.mcauley@empower Clinics.com
+1 855-855-9058
Investors:
投資者:
Tamara Mason
Business Development &
Communications
t.mason@empowerclinics.com
+1 855-855-9058
塔瑪拉·梅森
業務發展和
通信
郵箱:t.mason@empower Clinics.com
+1 855-855-9058
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
對前瞻性陳述的免責聲明
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding the expected use of proceeds of the Financing and the expected timing of an interim and permanent replacement President of MediSure Canada Inc. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that the Financing may not be completed on the terms expected or at all, and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
本新聞稿包含適用於加拿大證券法的某些“前瞻性陳述”或“前瞻性資訊”(統稱為“前瞻性陳述”)。除有關歷史事實的陳述外,所有陳述均為前瞻性陳述,均基於截至本新聞稿發佈之日的預期、估計和預測。前瞻性表述常常可以用“計劃”、“繼續”、“預期”、“專案”、“打算”、“相信”、“預期”、“估計”、“可能”、“將”、“潛在”、“建議”和其他類似詞語,或某些事件或條件“可能”或“將”發生的資訊來識別。本新聞稿中的前瞻性陳述包括有關融資收益的預期用途以及臨時和永久接替MediSure加拿大公司總裁的預期時間的陳述。此類前瞻性陳述基於管理層目前已知的假設,受風險和不確定因素的影響,這些風險和不確定性可能會導致實際結果、業績或發展與前瞻性陳述中包含的大不相同,包括融資可能不按預期或根本不能完成的條款,以及公司無法控制的其他因素。不能保證前瞻性陳述中預期的任何事件都會發生,或者如果發生了,公司將從中獲得什麼好處。告誡讀者不要過度依賴本新聞稿中的前瞻性陳述,這些前瞻性陳述完全受這些警告性陳述的限制。除適用的證券法明確要求外,公司沒有義務更新或修改本新聞稿中的任何前瞻性陳述,除非適用的證券法明確要求,無論是由於新資訊、未來事件還是其他原因。
SOURCE: Empower Clinics Inc.
資料來源:Empower Clinics Inc.
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧